Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Elevance Health
(NYSE:ELV)
Intraday
$537.26
0
[0.00%]
After-Hours
$537.26
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$537.26
0
[0.00%]
At close: Apr 26
$537.26
0
[0.00%]
PreMarket: 4:16PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Elevance Health Stock (NYSE:ELV)
Elevance Health Stock (NYSE: ELV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 26, 2024
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 5 Years
Benzinga Insights
-
2 days ago
Top 4 Health Care Stocks That May Plunge This Month
Avi Kapoor
-
2 days ago
Thursday, April 25, 2024
Looking Into Elevance Health's Recent Short Interest
Benzinga Insights
-
3 days ago
Wednesday, April 24, 2024
Decoding 13 Analyst Evaluations For Elevance Health
Benzinga Insights
-
4 days ago
Mizuho Maintains Buy on Elevance Health, Raises Price Target to $585
Benzinga Newsdesk
-
4 days ago
Sunday, April 21, 2024
Tracking Last Week's Top Performers: Are These 7 Large-Cap Stocks In Your Portfolio? (April 13-20, 2024)
Lekha Gupta
-
Apr 21, 2024, 6:14PM
Friday, April 19, 2024
RBC Capital Maintains Outperform on Elevance Health, Raises Price Target to $575
Benzinga Newsdesk
-
Apr 19, 2024, 1:05PM
UBS Maintains Buy on Elevance Health, Raises Price Target to $605
Benzinga Newsdesk
-
Apr 19, 2024, 10:32AM
Wells Fargo Maintains Overweight on Elevance Health, Raises Price Target to $600
Benzinga Newsdesk
-
Apr 19, 2024, 10:11AM
Truist Securities Reiterates Buy on Elevance Health, Raises Price Target to $600
Benzinga Newsdesk
-
Apr 19, 2024, 9:23AM
Elevance Health Analysts Boost Their Forecasts After Upbeat Earnings
Avi Kapoor
-
Apr 19, 2024, 9:02AM
Jefferies Maintains Buy on Elevance Health, Raises Price Target to $604
Benzinga Newsdesk
-
Apr 19, 2024, 8:39AM
Barclays Maintains Overweight on Elevance Health, Raises Price Target to $621
Benzinga Newsdesk
-
Apr 19, 2024, 8:36AM
Thursday, April 18, 2024
Benzinga Opening Bell Update: TSM Falls After Earnings, Semis Drop, Elevance Lifts Healthcare Stocks
Benzinga Newsdesk
-
Apr 18, 2024, 10:06AM
Elevance Health Clocks $2.2B Q1 Net Profit Despite 21% Drop In Medicaid Enrollment, Lifts Annual Guidance
Vandana Singh
-
Apr 18, 2024, 9:58AM
Elevance Health shares are trading higher after the company reported better-than-expected Q1 EPS and raised its FY23 guidance.
Benzinga Newsdesk
-
Apr 18, 2024, 8:52AM
Earnings Scheduled For April 18, 2024
Benzinga Insights
-
Apr 18, 2024, 8:10AM
Elevance Health Forecasts 2024 Revises FY2024 Adjusted EPS Guidance To Over $37.20 Versus Prior Outlook Of Over $37.10 And Consensus Of $37.15
Benzinga Newsdesk
-
Apr 18, 2024, 6:05AM
Elevance Health Q1 2024 Adj EPS $10.64 Beats $10.53 Estimate, Sales $42.273B Miss $42.626B Estimate
Benzinga Newsdesk
-
Apr 18, 2024, 6:02AM
Tuesday, April 16, 2024
Shares of healthcare stocks are trading higher in sympathy with UnitedHealth, which reported better-than-expected Q1 earnings.
Benzinga Newsdesk
-
Apr 16, 2024, 7:17AM
Monday, April 15, 2024
See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina
Vandana Singh
-
Apr 15, 2024, 2:17PM
Elevance Health, CD&R Announce Agreement To Form Strategic Partnership To Accelerate Primary Care Delivery
Benzinga Newsdesk
-
Apr 15, 2024, 7:05AM
Friday, April 12, 2024
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $11,000 Today
Benzinga Insights
-
Apr 12, 2024, 12:00PM
Wednesday, April 10, 2024
Cantor Fitzgerald Reiterates Overweight on Elevance Health, Maintains $580 Price Target
Benzinga Newsdesk
-
Apr 10, 2024, 10:11AM
Monday, April 08, 2024
Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $557
Benzinga Newsdesk
-
Apr 8, 2024, 8:33AM
Thursday, April 04, 2024
Deep Dive Into Elevance Health Stock: Analyst Perspectives (7 Ratings)
Benzinga Insights
-
Apr 4, 2024, 2:01PM
Cantor Fitzgerald Reiterates Overweight on Elevance Health, Maintains $580 Price Target
Benzinga Newsdesk
-
Apr 4, 2024, 10:06AM
Wednesday, April 03, 2024
Healthcare Stocks Take a Hit After Trepidation In the Market Continues
MarketBeat
-
Apr 3, 2024, 6:05PM
Tuesday, April 02, 2024
Israel Kills Top Iranian General – Oil Rises – Not Great For Stock Market's No Inflation Story
The Arora Report
-
Apr 2, 2024, 10:57AM
Shares of healthcare providers are trading lower after the CMS finalized payment updates for the 2025 Medicare Advantage and Medicare Part D programs.
Benzinga Newsdesk
-
Apr 2, 2024, 7:04AM
Monday, April 01, 2024
Shares of several healthcare providers are trading lower after the CMS finalized payment updates for the 2025 Medicare Advantage and Medicare Part D programs.
Benzinga Newsdesk
-
Apr 1, 2024, 4:35PM
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
Benzinga Insights
-
Apr 1, 2024, 4:30PM
Thursday, March 28, 2024
How Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows
Vandana Singh
-
Mar 28, 2024, 12:54PM
Elevance, CVS Health Are First Medicare Insurers To Cover Novo Nordisk's Weight Loss Sensation Wegovy
Vandana Singh
-
Mar 28, 2024, 10:25AM
Tuesday, March 26, 2024
How Is The Market Feeling About Elevance Health?
Benzinga Insights
-
Mar 26, 2024, 1:00PM
Tuesday, March 19, 2024
Kroger Passes The Baton: Sells Specialty Pharmacy Division To CarelonRx
Lekha Gupta
-
Mar 19, 2024, 12:18PM
Monday, March 18, 2024
Kroger Announces Definitive Agreement For Sale Of Its Specialty Pharmacy Business; Transaction Subject To Customary Closing Conditions And Expected To Close H2 2024
Benzinga Newsdesk
-
Mar 18, 2024, 4:20PM
Wednesday, March 13, 2024
$100 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today
Benzinga Insights
-
Mar 13, 2024, 11:30AM
Wednesday, March 06, 2024
Analyst Scoreboard: 6 Ratings For Elevance Health
Benzinga Insights
-
Mar 6, 2024, 9:00AM
Barclays Initiates Coverage On Elevance Health with Overweight Rating, Announces Price Target of $584
Benzinga Newsdesk
-
Mar 6, 2024, 6:30AM
Monday, March 04, 2024
The Centers For Medicare & Medicaid Services Informed Elevance Health's Four Medicare Advantage Contracts Will Have A Higher 2024 Star Rating Because Of Updated The Original Ratings Announced In October 2023 - 8K
Benzinga Newsdesk
-
Mar 4, 2024, 6:18AM
Elevance Health Reaffirms 2024 Net Income Guidance Of Greater Than $34.29 Per Diluted Share, And Greater Than $37.10 On Adjusted Basis Versus Consensus Of $37.05 - 8K
Benzinga Newsdesk
-
Mar 4, 2024, 6:16AM
Thursday, February 29, 2024
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,500 Today
Benzinga Insights
-
Feb 29, 2024, 1:00PM
Wednesday, February 14, 2024
Peeling Back The Layers: Exploring Elevance Health Through Analyst Insights
Benzinga Insights
-
Feb 14, 2024, 9:00AM
Cantor Fitzgerald Maintains Overweight on Elevance Health, Raises Price Target to $580
Benzinga Newsdesk
-
Feb 14, 2024, 8:45AM
Tuesday, February 13, 2024
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,200 Today
Benzinga Insights
-
Feb 13, 2024, 3:30PM
Friday, February 02, 2024
Cantor Fitzgerald Reiterates Overweight on Elevance Health, Maintains $547 Price Target
Benzinga Newsdesk
-
Feb 2, 2024, 10:09AM
Thursday, February 01, 2024
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Today
Benzinga Insights
-
Feb 1, 2024, 9:00AM
Thursday, January 25, 2024
Cantor Fitzgerald Reiterates Overweight on Elevance Health, Maintains $547 Price Target
Benzinga Newsdesk
-
Jan 25, 2024, 2:12PM
Navigating 4 Analyst Ratings For Elevance Health
Benzinga Insights
-
Jan 25, 2024, 12:01PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch